Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Hemodialysis and hemodiafiltration differently modulate left ventricular diastolic function

Authors: Árpád Czifra, Alida Páll, Julianna Kulcsár, Kitti Barta, Attila Kertész, György Paragh, István Lőrincz, Zoltán Jenei, Anupam Agarwal, Abolfazl Zarjou, József Balla, Zoltán Szabó

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Renal replacement therapy may have a favorable effect on diastolic left ventricular function, but it is not clear whether hemodiafiltration is superior to hemodialysis in this field. Nitric oxide (NO) and asymmetric dimethylarginine (ADMA) may play a role in the changes of intracardiac hemodynamics, but it is not clear whether the different renal replacement methods have disparate influence on the metabolism of these materials.

Methods

Thirty patients on renal replacement therapy were investigated. First, data was analyzed while patients received hemodiafiltration over a period of three months. Then, the same patients were evaluated during treatment with hemodialysis for at least another three months. Echocardiography was performed before and after renal replacement therapy.

Results

No significant difference was found in the volume removals between hemodialysis and hemodiafiltration. The left atrial diameter and transmitral flow velocities (E/A) decreased significantly only during hemodiafiltration. A positive correlation was observed between the left atrial diameter and E/Ea representing the left ventricular pressure load during hemodiafiltration. Significant correlations between NO and A and E/A were observed only in the case of hemodiafiltration.

Conclusion

Hemodiafiltration has a beneficial effect on echocardiographic markers representing left ventricular diastolic function. This could be attributed to the differences between the dynamics of volume removal and its distribution among liquid compartments.
Appendix
Available only for authorised users
Literature
1.
go back to reference McCullough PA, Steigerwalt S, Tolia K, Chen SC, Li S, Norris KC, Whaley-Connell A, KEEP Investigators: Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP). Curr Diab Rep. 2011, 11 (1): 47-55. 10.1007/s11892-010-0162-y.CrossRefPubMedPubMedCentral McCullough PA, Steigerwalt S, Tolia K, Chen SC, Li S, Norris KC, Whaley-Connell A, KEEP Investigators: Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP). Curr Diab Rep. 2011, 11 (1): 47-55. 10.1007/s11892-010-0162-y.CrossRefPubMedPubMedCentral
2.
go back to reference Arora N, Dellsperger KC: Heart failure and dialysis: new thoughts and trends. Adv Perit Dial. 2007, 23: 72-76.PubMed Arora N, Dellsperger KC: Heart failure and dialysis: new thoughts and trends. Adv Perit Dial. 2007, 23: 72-76.PubMed
3.
go back to reference Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int. 1995, 47 (3): 884-890. 10.1038/ki.1995.132.CrossRefPubMed Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int. 1995, 47 (3): 884-890. 10.1038/ki.1995.132.CrossRefPubMed
4.
go back to reference Douchet MP, Couppie P, Chantrel F, Kuntz C, Hannedouche T: Diastolic dysfunction in chronic renal failure patients under hemodialysis. Ann Cardiol Angeiol (Paris). 1996, 45 (10): 589-592. Douchet MP, Couppie P, Chantrel F, Kuntz C, Hannedouche T: Diastolic dysfunction in chronic renal failure patients under hemodialysis. Ann Cardiol Angeiol (Paris). 1996, 45 (10): 589-592.
5.
go back to reference Meyer C, Heiss C, Drexhage C, Kehmeier ES, Balzer J, Muhlfeld A, Merx MW, Lauer T, Kuhl H, Floege J, Kelm M, Rassaf T: Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function. J Am Coll Cardiol. 2010, 55 (5): 454-459. 10.1016/j.jacc.2009.07.068.CrossRefPubMed Meyer C, Heiss C, Drexhage C, Kehmeier ES, Balzer J, Muhlfeld A, Merx MW, Lauer T, Kuhl H, Floege J, Kelm M, Rassaf T: Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function. J Am Coll Cardiol. 2010, 55 (5): 454-459. 10.1016/j.jacc.2009.07.068.CrossRefPubMed
6.
go back to reference Kimura K, Tabei K, Asano Y, Hosoda S: Cardiac arrhythmias in hemodialysis patients. A study of incidence and contributory factors. Nephron. 1989, 53 (3): 201-207. 10.1159/000185745.CrossRefPubMed Kimura K, Tabei K, Asano Y, Hosoda S: Cardiac arrhythmias in hemodialysis patients. A study of incidence and contributory factors. Nephron. 1989, 53 (3): 201-207. 10.1159/000185745.CrossRefPubMed
7.
go back to reference Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, Klassen P, Port FK: Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int. 2006, 69 (11): 2087-2093. 10.1038/sj.ki.5000447.CrossRefPubMed Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, Klassen P, Port FK: Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int. 2006, 69 (11): 2087-2093. 10.1038/sj.ki.5000447.CrossRefPubMed
8.
go back to reference Vanholder R, Meert N, Schepers E, Glorieux G: From uremic toxin retention to removal by convection: do we know enough?. Contrib Nephrol. 2008, 161: 125-131.CrossRefPubMed Vanholder R, Meert N, Schepers E, Glorieux G: From uremic toxin retention to removal by convection: do we know enough?. Contrib Nephrol. 2008, 161: 125-131.CrossRefPubMed
9.
go back to reference Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D: Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney Int. 1999, 55 (1): 286-293. 10.1046/j.1523-1755.1999.00236.x.CrossRefPubMed Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D: Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney Int. 1999, 55 (1): 286-293. 10.1046/j.1523-1755.1999.00236.x.CrossRefPubMed
10.
go back to reference Kerr PB, Argiles A, Flavier JL, Canaud B, Mion CM: Comparison of hemodialysis and hemodiafiltration: a long-term longitudinal study. Kidney Int. 1992, 41 (4): 1035-1040. 10.1038/ki.1992.157.CrossRefPubMed Kerr PB, Argiles A, Flavier JL, Canaud B, Mion CM: Comparison of hemodialysis and hemodiafiltration: a long-term longitudinal study. Kidney Int. 1992, 41 (4): 1035-1040. 10.1038/ki.1992.157.CrossRefPubMed
11.
go back to reference Canaud B, Wizemann V, Pizzarelli F, Greenwood R, Schultze G, Weber C, Falkenhagen D: Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy. Nephrol Dial Transplant. 2001, 16 (11): 2181-2187. 10.1093/ndt/16.11.2181.CrossRefPubMed Canaud B, Wizemann V, Pizzarelli F, Greenwood R, Schultze G, Weber C, Falkenhagen D: Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy. Nephrol Dial Transplant. 2001, 16 (11): 2181-2187. 10.1093/ndt/16.11.2181.CrossRefPubMed
12.
go back to reference Spalding EM, Chamney PW, Farrington K: Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int. 2002, 61 (2): 655-667. 10.1046/j.1523-1755.2002.00146.x.CrossRefPubMed Spalding EM, Chamney PW, Farrington K: Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int. 2002, 61 (2): 655-667. 10.1046/j.1523-1755.2002.00146.x.CrossRefPubMed
13.
go back to reference Zehnder C, Gutzwiller JP, Renggli K: Hemodiafiltration–a new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol. 1999, 52 (3): 152-159.PubMed Zehnder C, Gutzwiller JP, Renggli K: Hemodiafiltration–a new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol. 1999, 52 (3): 152-159.PubMed
14.
go back to reference Panichi V, Paoletti S, Consani C: Inflammatory pattern in hemodiafiltration. Contrib Nephrol. 2008, 161: 185-190.CrossRefPubMed Panichi V, Paoletti S, Consani C: Inflammatory pattern in hemodiafiltration. Contrib Nephrol. 2008, 161: 185-190.CrossRefPubMed
15.
go back to reference van Tellingen A, Grooteman MP, Schoorl M, Bartels PC, Schoorl M, van der Ploeg T, ter Wee PM, Nube MJ: Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients. Kidney Int. 2002, 62 (2): 632-638. 10.1046/j.1523-1755.2002.00470.x.CrossRefPubMed van Tellingen A, Grooteman MP, Schoorl M, Bartels PC, Schoorl M, van der Ploeg T, ter Wee PM, Nube MJ: Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients. Kidney Int. 2002, 62 (2): 632-638. 10.1046/j.1523-1755.2002.00470.x.CrossRefPubMed
16.
go back to reference Deppisch RM, Beck W, Goehl H, Ritz E: Complement components as uremic toxins and their potential role as mediators of microinflammation. Kidney Int Suppl. 2001, 78: S271-S277.CrossRefPubMed Deppisch RM, Beck W, Goehl H, Ritz E: Complement components as uremic toxins and their potential role as mediators of microinflammation. Kidney Int Suppl. 2001, 78: S271-S277.CrossRefPubMed
17.
go back to reference Koda Y, Nishi S, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, Sakai S, Yuasa Y, Hirasawa Y, Nishi T: Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int. 1997, 52 (4): 1096-1101. 10.1038/ki.1997.434.CrossRefPubMed Koda Y, Nishi S, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, Sakai S, Yuasa Y, Hirasawa Y, Nishi T: Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int. 1997, 52 (4): 1096-1101. 10.1038/ki.1997.434.CrossRefPubMed
18.
go back to reference Schwalbe S, Holzhauer M, Schaeffer J, Galanski M, Koch KM, Floege J: Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis?. Kidney Int. 1997, 52 (4): 1077-1083. 10.1038/ki.1997.431.CrossRefPubMed Schwalbe S, Holzhauer M, Schaeffer J, Galanski M, Koch KM, Floege J: Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis?. Kidney Int. 1997, 52 (4): 1077-1083. 10.1038/ki.1997.431.CrossRefPubMed
19.
go back to reference Blankestijn PJ, Vos PF, Rabelink TJ, van Rijn HJ, Jansen H, Koomans HA: High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol. 1995, 5 (9): 1703-1708.PubMed Blankestijn PJ, Vos PF, Rabelink TJ, van Rijn HJ, Jansen H, Koomans HA: High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol. 1995, 5 (9): 1703-1708.PubMed
20.
go back to reference Ward RA, McLeish KR: Oxidant stress in hemodialysis patients: what are the determining factors?. Artif Organs. 2003, 27 (3): 230-236. 10.1046/j.1525-1594.2003.07170.x.CrossRefPubMed Ward RA, McLeish KR: Oxidant stress in hemodialysis patients: what are the determining factors?. Artif Organs. 2003, 27 (3): 230-236. 10.1046/j.1525-1594.2003.07170.x.CrossRefPubMed
21.
go back to reference Raj DS, Vincent B, Simpson K, Sato E, Jones KL, Welbourne TC, Levi M, Shah V, Blandon P, Zager P, Robbins RA: Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin. Kidney Int. 2002, 61 (2): 697-704. 10.1046/j.1523-1755.2002.00150.x.CrossRefPubMed Raj DS, Vincent B, Simpson K, Sato E, Jones KL, Welbourne TC, Levi M, Shah V, Blandon P, Zager P, Robbins RA: Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin. Kidney Int. 2002, 61 (2): 697-704. 10.1046/j.1523-1755.2002.00150.x.CrossRefPubMed
22.
go back to reference Bonforte G, Grillo P, Zerbi S, Surian M: Improvement of anemia in hemodialysis patients treated by hemodiafiltration with high-volume on-line-prepared substitution fluid. Blood Purif. 2002, 20 (4): 357-363. 10.1159/000063104.CrossRefPubMed Bonforte G, Grillo P, Zerbi S, Surian M: Improvement of anemia in hemodialysis patients treated by hemodiafiltration with high-volume on-line-prepared substitution fluid. Blood Purif. 2002, 20 (4): 357-363. 10.1159/000063104.CrossRefPubMed
23.
go back to reference McMahon LP: Hemodynamic cardiovascular risk factors in chronic kidney disease: what are the effects of intervention?. Semin Dial. 2003, 16 (2): 128-139.CrossRefPubMed McMahon LP: Hemodynamic cardiovascular risk factors in chronic kidney disease: what are the effects of intervention?. Semin Dial. 2003, 16 (2): 128-139.CrossRefPubMed
24.
go back to reference Hayashi SY, Brodin LA, Alvestrand A, Lind B, Stenvinkel P, Mazza do Nascimento M, Qureshi AR, Saha S, Lindholm B, Seeberger A: Improvement of cardiac function after haemodialysis. Quantitative evaluation by colour tissue velocity imaging. Nephrol Dial Transplant. 2004, 19 (6): 1497-1506. 10.1093/ndt/gfh205.CrossRefPubMed Hayashi SY, Brodin LA, Alvestrand A, Lind B, Stenvinkel P, Mazza do Nascimento M, Qureshi AR, Saha S, Lindholm B, Seeberger A: Improvement of cardiac function after haemodialysis. Quantitative evaluation by colour tissue velocity imaging. Nephrol Dial Transplant. 2004, 19 (6): 1497-1506. 10.1093/ndt/gfh205.CrossRefPubMed
25.
go back to reference Ohtake T, Oka M, Ishioka K, Honda K, Mochida Y, Maesato K, Moriya H, Hidaka S, Kobayashi S: Cardiovascular protective effects of on-line hemodiafiltration: comparison with conventional hemodialysis. Ther Apher Dial. 2012, 16 (2): 181-188. 10.1111/j.1744-9987.2011.01042.x.CrossRefPubMed Ohtake T, Oka M, Ishioka K, Honda K, Mochida Y, Maesato K, Moriya H, Hidaka S, Kobayashi S: Cardiovascular protective effects of on-line hemodiafiltration: comparison with conventional hemodialysis. Ther Apher Dial. 2012, 16 (2): 181-188. 10.1111/j.1744-9987.2011.01042.x.CrossRefPubMed
Metadata
Title
Hemodialysis and hemodiafiltration differently modulate left ventricular diastolic function
Authors
Árpád Czifra
Alida Páll
Julianna Kulcsár
Kitti Barta
Attila Kertész
György Paragh
István Lőrincz
Zoltán Jenei
Anupam Agarwal
Abolfazl Zarjou
József Balla
Zoltán Szabó
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-76

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.